These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37622457)

  • 1. Ileus induced by the combination of vinca alkaloids and posaconazole in a patient with acute lymphoblastic leukemia: a case report and literature review.
    Li Y; Gong YH; Zhao MF; Xiao X; Wei XC
    J Int Med Res; 2023 Aug; 51(8):3000605231193823. PubMed ID: 37622457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posaconazole-increased vincristine neurotoxicity in a child: a case report.
    Eiden C; Palenzuela G; Hillaire-Buys D; Margueritte G; Cociglio M; Hansel-Esteller S; Peyriere H
    J Pediatr Hematol Oncol; 2009 Apr; 31(4):292-5. PubMed ID: 19346885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy.
    Park H; Youk J; Shin DY; Hong J; Kim I; Kim NJ; Lee JO; Bang SM; Yoon SS; Park WB; Koh Y
    BMC Cancer; 2019 Apr; 19(1):358. PubMed ID: 30991992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posaconazole and fluconazole prophylaxis during induction therapy for pediatric acute lymphoblastic leukemia.
    Zhang T; Bai J; Huang M; Li R; Liu Y; Liu A; Liu J
    J Microbiol Immunol Infect; 2021 Dec; 54(6):1139-1146. PubMed ID: 32828790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of vincristine-induced ileus with metoclopramide: A case report.
    Masoumi HT; Hadjibabaie M; Zarif-Yeganeh M; Khajeh B; Ghavamzadeh A
    J Oncol Pharm Pract; 2019 Mar; 25(2):507-511. PubMed ID: 29224457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicity of Vincristine Combined With Posaconazole in Children With Acute Lymphoblastic Leukemia.
    Pekpak E; İleri T; İnce E; Ertem M; Uysal Z
    J Pediatr Hematol Oncol; 2018 Jul; 40(5):e309-e310. PubMed ID: 29219892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Posaconazole Really Effective in Adolescent patients as a Prophylactic Agent: Experience of a Tertiary Care Center.
    Arikan K; Aytac S; Büyükcam A; Cengiz AB; Cetinkaya FD; Cetin M; Ozsurekci Y; Ceyhan M; Kara A
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):e613-e618. PubMed ID: 33560081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
    Vats T; Buchanan G; Mehta P; Ragab A; Hvizdale E; Nitschke R; Link M; Beardsley GP; Maybee D; Krischer J
    Invest New Drugs; 1992 Aug; 10(3):231-4. PubMed ID: 1428733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole-enhanced vindesine neurotoxicity in adult acute lymphoblastic leukaemia.
    Chen S; Wu D; Sun A; Qiu H; Jin Z; Tang X; Miao M; Fu Z; Ma X; Han Y; Hu X
    Am J Hematol; 2007 Oct; 82(10):942. PubMed ID: 17617780
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
    Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
    Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of 3 cases of mucormycosis in children with acute lymphoblastic leukemia and literature review].
    Sun HY; Li B; Liu Y; You HL; Liu YF
    Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):56-61. PubMed ID: 34986625
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe Neuropathic Pain With Concomitant Administration of Vincristine and Posaconazole.
    Lin MJ; Paul MR; Kuo DJ
    J Pediatr Pharmacol Ther; 2018; 23(5):417-420. PubMed ID: 30429697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Itraconazole-related increased vincristine neurotoxicity: case report and review of literature.
    Bermúdez M; Fuster JL; Llinares E; Galera A; Gonzalez C
    J Pediatr Hematol Oncol; 2005 Jul; 27(7):389-92. PubMed ID: 16012330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lubiprostone on vinca alkaloid-induced constipation in patients with hematological malignancies: a propensity score-matched analysis.
    Kawada K; Ohta T; Fukuda H; Hayashi T; Tanaka K; Imai T; Morita Y; Miyamura M
    Ann Hematol; 2020 Oct; 99(10):2429-2436. PubMed ID: 32839869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole prophylaxis in leukemic patients: A retrospective single-center study.
    Bui V; Walker SA; Elligsen M; Vyas A; Kiss A; Palmay L
    J Oncol Pharm Pract; 2020 Jun; 26(4):873-881. PubMed ID: 31566111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
    Yasu T; Ohno N; Kawamata T; Kurokawa Y
    Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
    Harnicar S; Adel N; Jurcic J
    J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia and liver failure.
    Sterba J; Prochazka J; Ventruba J; Kren L; Valik D; Burgetova D; Mudry P; Skotakova J; Blatny J
    Pediatr Hematol Oncol; 2005 Dec; 22(8):649-55. PubMed ID: 16251170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome.
    Phillips K; Cirrone F; Ahuja T; Siegfried J; Papadopoulos J
    J Oncol Pharm Pract; 2019 Mar; 25(2):398-403. PubMed ID: 30319061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.